An interventional study of Clean Indoor Air Exposure (Control) and Exposure to Cooking-Generated Ultrafine Particles and Gases in Cognitive Function Decline, Air Pollution Exposure and Respiratory Inflammation, sponsored by University of Illinois at Chicago. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-31.
Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Signs and Symptoms, Respiratory with a site in United States — 2 open to participants now, 3 under way, none of them phase 3. Signs and Symptoms, Respiratory · United States.
Among the 17 studies in Signs and Symptoms, Respiratory with a site in United States, this one is the 14th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2026, is one of 9 with no phase, and was the 16th registered.
64 studies on the registry are indexed under Signs and Symptoms, Respiratory; 9 are open to participants now.
Browse Signs and Symptoms, Respiratory studies →2 of the 17 studies in Signs and Symptoms, Respiratory with a site in United States are open now. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 60+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 5 Signs and Symptoms, Respiratory studies recruiting now, 4 set no upper age limit and 1 stops at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 120 across 43 interventional studies indexed under Signs and Symptoms, Respiratory.
Median enrollment 129 across the 14 interventional studies, 87 across the 3 observational. Of the 14 that completed or were terminated, 5 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 17 have an industry lead sponsor. The 10 most frequent:
University of Illinois at Chicago is the lead sponsor of 496 studies on the registry; 115 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.
University of Illinois at Chicago has 1 study filed under Signs and Symptoms, Respiratory — fewer than ten, so there is no comparison to draw.
1 of the studies in Signs and Symptoms, Respiratory with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04179981VA Office of Research and DevelopmentImpact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome) | 2027-09-30 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies in Signs and Symptoms, Respiratory with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study examines the short-term respiratory and cognitive effects of exposure to ultrafine particles (UFPs) generated during typical household cooking. Healthy adults will complete two 6-hour sessions in a controlled exposure chamber at the University of Illinois Chicago: one control day with clean indoor air and one exposure day during which standardized cooking (frying potatoes and grilling beef) is performed by research staff. Participants will not cook or handle food. Lung function will be measured using peak expiratory flow (PEF), and cognitive performance will be assessed using validated tests including the Hopkins Verbal Learning Test-Revised and the Processing Speed Index from the WAIS-IV. Airborne particle and gas concentrations in the chamber will be continuously monitored to ensure that exposures remain within levels typical of everyday home cooking. Findings will help characterize acute physiological responses to indoor cooking emissions and inform future research on indoor air quality and potential mitigation strategies.
This study evaluates the short-term respiratory and cognitive responses to controlled exposure to cooking-generated ultrafine particles (UFPs). Cooking emissions are one of the most common sources of indoor particulate pollution, yet their acute physiological effects remain poorly characterized. To address this gap, the study uses a controlled exposure chamber environment that reproduces typical household cooking conditions while allowing precise measurement of airborne particle and gas concentrations.
Healthy adult volunteers will participate in two study sessions conducted on consecutive days. On the exposure day, research staff will prepare a standardized meal (frying potatoes and grilling beef) inside the chamber to generate UFPs and co-emitted gases at levels representative of home cooking. On the control day, participants remain in the same chamber but without any cooking activity. Participants will spend approximately six hours in the chamber each day and will remain at rest except during scheduled assessments.
The study employs a randomized two-period crossover design so each participant serves as their own control. Lung function and cognitive performance are assessed multiple times on each day using validated instruments. Air quality is monitored continuously using particle sizing instruments, particle mass monitors, and a gas analyzer to characterize exposure conditions. Pre-defined stopping rules and ventilation procedures are implemented if concentrations exceed levels typical of household cooking.
This study is designed to generate preliminary U.S.-based data on the immediate effects of cooking-related UFP exposure on respiratory function and cognitive performance. Findings will help define exposure-response patterns, support future NIH and American Lung Association proposals, and improve understanding of indoor air quality impacts in everyday environments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults 18 years of age or older
Able to understand and speak English sufficiently to complete cognitive testing
Able and willing to complete two consecutive study sessions lasting approximately 6 hours each
Able to avoid cooking, toasting, and fume-generating household activities (e.g., strong cleaning products, ironing, hair drying) for 24 hours before each session
Able to avoid tobacco, marijuana, vaping, and alcohol use as specified in the study protocol
Able to provide
Exclusion Criteria
Younger than 18 years old
Pregnant or planning pregnancy during study participation
Current smoking or use of:
Cigarettes
E-cigarettes or vaping devices
Marijuana
Shisha/hookah
Binge drinking, heavy alcohol use, or inability to abstain from alcohol for 24 hours before study visits
Restaurant chefs or individuals who perform frequent commercial-level cooking
Individuals who cook two or more frying or grilling meals per day at home
Cooking anxiety or mageirocophobia
Any diagnosed neurological disease, including stroke, seizure disorder, multiple sclerosis, traumatic brain injury, dementia, or similar conditions
Any significant respiratory disease, including:
(COPD)
Untreated severe asthma
Chronic bronchitis or other major lung disease
Any significant psychiatric condition, including:
Schizophrenia spectrum disorder
Untreated substance use disorder
Severe mood disorder
Severe anxiety disorder
Claustrophobia or anxiety in enclosed spaces (if severe enough to interfere with chamber procedures)
Inability to comply with study procedures or safety requirements
Any medical or psychological condition that, in the judgement of the investigators, may increase risk or interfere with study participation
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will complete a control study session conducted in a controlled exposure chamber with clean indoor air and no cooking activity. Respiratory, cognitive, and physiological outcomes will be assessed during the session.
Other: Clean Indoor Air Exposure (Control)
Participants will complete an exposure study session conducted in the same controlled exposure chamber during which cooking activities generate ultrafine particles. Respiratory, cognitive, and physiological outcomes will be assessed during the session.
Other: Exposure to Cooking-Generated Ultrafine Particles and Gases
Participants will be exposed to clean indoor air in a controlled exposure chamber with no cooking activity. This condition serves as the control session for within-subject comparisons.
Participants will be exposed to cooking-generated ultrafine particles and associated gases in a controlled exposure chamber during standardized cooking activities.
Change in Hopkins Verbal Learning Test-Revised (HVLT-R) Total Recall Score
Cognitive performance related to verbal memory will be assessed using the Hopkins Verbal Learning Test-Revised (HVLT-R). The primary metric will be the change in HVLT-R Total Recall Score between exposure and control conditions, calculated from repeated assessments to evaluate short-term cognitive effects of ultrafine particle exposure.
Time frame: Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study days
Change in Peak Expiratory Flow (PEF)
Peak Expiratory Flow (PEF) will be measured using a handheld peak flow meter to assess short-term changes in lung function following exposure to cooking-generated ultrafine particles compared with the clean-air control day. Changes are evaluated within subjects using repeated measurements across both conditions.
Time frame: Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study days
Change in WAIS Symbol Search Raw Score
Cognitive performance related to processing speed and visual attention will be assessed using the Symbol Search subtest of the Wechsler Adult Intelligence Scale (WAIS). The primary metric will be the change in WAIS Symbol Search raw score between exposure and control conditions, calculated from repeated assessments to evaluate short-term cognitive effects of ultrafine particle exposure.
Time frame: Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study days
Ultrafine Particle Number Size Distribution in particles/cm3
Ultrafine particle number size distributions will be measured using a Scanning Mobility Particle Sizer (SMPS) and Partector 2 Pro. These measurements characterize exposure conditions and allow correlation with physiological responses.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods.
Fine Particle Mass Concentrations (PM2.5) in microgram/cm3
Particle mass concentrations (PM2.5) will be measured using a DustTrak DRX monitor to quantify particulate exposure profiles during cooking and control sessions. These measurements characterize exposure conditions and allow correlation with physiological responses.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
Total Volatile Organic Compound (VOC) concentration in ppm
Concentrations of over 50 volatile organic compounds (VOCs) will be monitored using FTIR spectroscopy (Gasmet DX4040) to characterize exposure to total VOC concentration during cooking. The concentration of individual gases will be add up to quantify total VOC concentration.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
CO2 concentration in ppm
Description: Concentrations of CO2 will be monitored using Atmocube, Atmo, USA instrument. This measurement characterize exposure conditions and allow correlation with physiological responses.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
CO concentration in ppm
Description: Concentrations of CO will be monitored using FTIR spectroscopy (Gasmet DX4040) to characterize exposure to CO during cooking. The
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
NO2 concentration in ppm
Concentrations of NO2 will be monitored using FTIR spectroscopy (Gasmet DX4040) to characterize exposure to NO2 during cooking.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
Temperature Condition in Exposure Chamber
Ambient temperature will be recorded to ensure environmental conditions remain consistent and to support interpretation of particle behavior.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
Number of Participants Reporting Acute Symptoms During Study Sessions
Participant-reported symptoms related to tolerability of the study procedures and exposure will be assessed using a standardized symptom checklist administered by study staff. Symptoms assessed will include throat or eye irritation, cough, headache, dizziness, and nausea. The outcome measure will be the number of participants reporting one or more symptoms during each study session.
Time frame: Assessed at baseline and at approximately 1, 2, 3, and 5 hours after session start on control and exposure days
Relative Humidity Condition in Exposure Chamber
Relative Humidity in the chamber will be recorded to ensure environmental conditions remain consistent and to support interpretation of particle behavior.
Time frame: Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods
Plan to share: No — Individual participant data (IPD) will not be shared because this study does not collect biospecimens and all data are used solely for the analyses specified in the protocol. Data are stored in coded form and are not intended for secondary research use. In addition, screening data for ineligible individuals are destroyed within 3 days, and no identifiable information is retained beyond what is required for regulatory documentation. Only aggregate, de-identified results may be shared with participants upon request, but individual-level datasets will not be made available to external researchers.
No publications or documents are linked to this record.
Start is estimated for Jan 2026; primary completion for Mar 2026, 1 month later.
Of 18 interventional studies with no phase under Signs and Symptoms, Respiratory, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 1 month is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Signs and Symptoms, Respiratory →
University of Illinois at Chicago →